Biomarkers of stroke -: clinical relevance in diagnosis and prognosis

被引：0
作者：
Sitzer, M. [1 ]
Dvorak, F. [1 ]
Foerch, C. [1 ]
机构：
[1] Univ Frankfurt Main Klinikum, Zentrum Neurol & Neurochirurg, Klin Neurol, D-60529 Frankfurt, Germany
来源：
NERVENHEILKUNDE | 2007年 / 26卷 / 05期
关键词：
ischemic stroke; hemorrhagic stroke; blood serum marker; biomarker; diagnosis; prognosis;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
In the past, a numerous amount of blood serum biomarkers were analysed concerning their significance of relation with cerebrovascular diseases. Alongside the diagnosis and differentiation of an acute stroke-syndrome, the individual future prospects in various clinical situations are in the foreground. The application of S100B and cellular fibronectin seems to be the most reliable and precise application of blood serum biomarker to predict a malignant course of acute middle cerebral artery infarction at the moment. Despite the various amount of clinical trials, there is no concrete prospect of clinical application at this point. Surely the conduction of dimensioned clinical trials concerning these pilot studies will be necessary in order to evaluate the specified meaning of blood serum biomarkers and their combination with clinically relevant questionings. The state of affairs can be gathered from the present article.
引用
收藏
页码：352 / +
页数：4
相关论文
共 17 条
[1]   PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke [J].
Allard, L ;
Burkhard, PR ;
Lescuyer, P ;
Burgess, JA ;
Walter, N ;
Hochstrasser, DF ;
Sanchez, JC .
CLINICAL CHEMISTRY, 2005, 51 (11) :2043-2051
[2]   ApoC-I and ApoC-III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke [J].
Allard, L ;
Lescuyer, P ;
Burgess, J ;
Leung, KY ;
Ward, M ;
Walter, N ;
Burkhard, PR ;
Corthals, G ;
Hochstrasser, DF ;
Sanchez, JC .
PROTEOMICS, 2004, 4 (08) :2242-2251
[3]   Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke [J].
Castellanos, M ;
Leira, R ;
Serena, J ;
Blanco, M ;
Pedraza, S ;
Castillo, J ;
Dávalos, A .
STROKE, 2004, 35 (07) :1671-1676
[4]   Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke [J].
Dambinova, SA ;
Khounteev, GA ;
Izykenova, GA ;
Zavolokov, IG ;
Ilyukhina, AY ;
Skoromets, AA .
CLINICAL CHEMISTRY, 2003, 49 (10) :1752-1762
[5]   Erythropoietin therapy for acute stroke is both safe and beneficial [J].
Ehrenreich, H ;
Hasselblatt, M ;
Dembowski, C ;
Cepek, L ;
Lewczuk, P ;
Stiefel, M ;
Rustenbeck, HH ;
Breiter, N ;
Jacob, S ;
Knerlich, F ;
Bohn, M ;
Poser, W ;
Rüther, E ;
Kochen, M ;
Gefeller, O ;
Gleiter, C ;
Wessel, TC ;
De Ryck, M ;
Itri, L ;
Prange, H ;
Cerami, A ;
Brines, M ;
Sirén, AL .
MOLECULAR MEDICINE, 2002, 8 (08) :495-505
[6]   Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke [J].
Foerch, C ;
Curdt, I ;
Yan, B ;
Dvorak, F ;
Hermans, M ;
Berkefeld, J ;
Raabe, A ;
Neumann-Haefelin, T ;
Steinmetz, H ;
Sitzer, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (02) :181-184
[7]   Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction [J].
Foerch, C ;
Singer, OC ;
Neumann-Haefelin, T ;
de Rochemont, RDM ;
Steinmetz, H ;
Sitzer, M .
ARCHIVES OF NEUROLOGY, 2005, 62 (07) :1130-1134
[8]   Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion [J].
Foerch, C ;
Otto, B ;
Singer, OC ;
Neumann-Haefelin, T ;
Yan, B ;
Berkefeld, J ;
Steinmetz, H ;
Sitzer, M .
STROKE, 2004, 35 (09) :2160-2164
[9]   S100B as a surrogate marker for successful clot lysis in hyperacute middle cerebral artery occlusion [J].
Foerch, C ;
de Rochemont, RD ;
Singer, O ;
Neumann-Haefelin, T ;
Buchkremer, M ;
Zanella, FE ;
Steinmetz, H ;
Sitzer, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (03) :322-325
[10]   Increase in plasma matrix metalloproteinase-9 in acute stroke patients with thrombolysis failure [J].
Heo, JH ;
Kim, SH ;
Lee, KY ;
Kim, EH ;
Chu, CK ;
Nam, JM .
STROKE, 2003, 34 (06) :E48-E50
12